Type 1 Diabetes

Boehringer Ingelheim and Eli Lilly have announced positive results from a phase 3 trial for Jardiance in reducing blood sugar levels in children with type 2 diabetes.

The US FDA announced the approval of teplizumab (Tzield), which is administered through IV infusion once daily for 14 consecutive days, for delaying the onset of stage 3 type 1 diabetes in adults and pediatric patients 8 years and older who currently have stage 2 type 1 diabetes.

Elaine M. Apperson, MD, reviews screening guidelines for the management of type 1 diabetes.

An expert pediatric endocrinologist addresses awareness of family history of type 1 diabetes as well as differentiating within type 1 and type 2 disease.

Dr Elaine M. Apperson defines each stage of type 1 diabetes and how progression may present in pediatric patients.

Elaine M. Apperson, MD, reviews the prevalence and risk factors in the pediatric population for type 1 diabetes.

An analysis of data from more than 9900 people with Down syndrome and 38,000 controls provides new insight into the apparent increase in risk of developing diabetes among children and young adults with Down syndrome.

In a recent presentation the NPWH 25th Annual Premier Women's Healthcare Conference, Jenny Madrid, MPH, RD, CDCES, BC-ADM, discussed medical nutrition therapy, a type of treatment plan for managing gestational diabetes by adjusting to an appropriate diet.

In a recent study, pediatric patients infected with COVID-19 were more likely to develop type 1 diabetes than those infected with other respiratory illnesses.

Results of the TARGET trial provide insight into the effects of tight glycemic targets versus less tight targets on maternal and perinatal outcomes among women with gestational diabetes.

Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES shares clinical pearls for the management of school aged children with diabetes.

An expert in diabetes education provides an overview of dosing requirements and appropriate administration requirements necessary for the administration of hypoglycemia rescue therapies.

Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES reviews the currently available rescue modalities for use in pediatric patients with diabetes experiencing severe hypoglycemia or very low blood sugar.

A certified diabetes educator comments on the some of the available resources for patients, their families, and school staff surrounding the management of diabetes in a school setting.

Investigators found minimal difference between breastfeeding rates less than 1 week postpartum of women who had diabetes pre-pregnancy, gestational diabetes only, and no history of diabetes.

An expert in diabetes education reviews the signs and symptoms of hypoglycemia and reviews the importance of having school staff members knowledgeable in their presentation.

Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES provide insight into the challenges inherent to the management of pediatric patients with diabetes, highlighting school related considerations.

Despite increasing the rate of diagnoses and healthcare utilization, the GEMS study found a lower glycemic criterion for diagnosis of gestational diabetes was not associated with a reduced risk of negative outcomes for mother and offspring.

Using electronic medical record data from 2018-2020 obtained from 24 medical centers across the US, including Johns Hopkins, University of Colorado, and Mayo Clinic institutions, a new study suggests rates of youth onset type 2 diabetes increased 77% during the first year of the pandemic.

Data from the US Department of Health and Human Services has shown an increase in GDM rate from 2016 to 2020, with a greater increase observed from 2019 to 2020.

New research indicates dulaglutide is effective in improving glycemic control in pediatric patients with diabetes.

New research suggests adolescent obesity could increase risk of type 1 diabetes in young adulthood.